US 11718612
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted A61KA61K31/4035A61K31/407
Quick answer
US patent 11718612 (Inhibitors of receptor interacting protein kinase I for the treatment of disease) held by The Board of Regents of the University of Texas System expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/4035, A61K31/407, A61K31/415, A61K31/4172